Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Secondary Pneumococcal Disease in Veterans With Viral Respiratory Infections: A Follow Up.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: September 30, 2025
Secondary Pneumococcal Disease in Veterans With Viral Respiratory Infections.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: March 20, 2025
New methods to detect bacterial or viral infections in patients with chronic obstructive pulmonary disease.
Journal: Expert review of respiratory medicine
Published: August 23, 2024
A Novel Cytotoxic Mechanism for Triple-Negative Breast Cancer Cells Induced by the Type II Heat-Labile Enterotoxin LT-IIc through Ganglioside Ligation.
Journal: Toxins
Published: April 01, 2024
Persistent neurological symptoms and elevated intracranial pressures in a previously healthy host with cryptococcal meningitis.
Journal: BMC infectious diseases
Published: January 06, 2023
LT-IIc, A Bacterial Type II Heat-Labile Enterotoxin, Induces Specific Lethality in Triple Negative Breast Cancer Cells by Modulation of Autophagy and Induction of Apoptosis and Necroptosis.
Journal: International journal of molecular sciences
Published: December 06, 2018
Novel Strategy To Protect against Influenza Virus-Induced Pneumococcal Disease without Interfering with Commensal Colonization.
Journal: Infection and immunity
Published: December 09, 2015
The Divergent CD8+ T Cell Adjuvant Properties of LT-IIb and LT-IIc, Two Type II Heat-Labile Enterotoxins, Are Conferred by Their Ganglioside-Binding B Subunits.
Journal: PloS one
Published: June 10, 2015
Enhancement of humoral immunity by the type II heat-labile enterotoxin LT-IIb is dependent upon IL-6 and neutrophils.
Journal: Journal of leukocyte biology
Published: April 15, 2015
LT-IIb(T13I), a non-toxic type II heat-labile enterotoxin, augments the capacity of a ricin toxin subunit vaccine to evoke neutralizing antibodies and protective immunity.
Journal: PloS one
Published: January 18, 2013
Showing 1-11 of 11
Last Updated: 09/26/2026